Bicuculline methiodide in the blood-brain barrier - epileptogen model of epilepsy

M. P. Remler, W. H. Marcussen

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Focal epilepsy can be produced by a blood-brain barrier (BBB)-excluded systemic convulsant (penicillin, folic acid, etc.) in the presence of a focal BBB lesion. Bicuculline methiodide, a γ-aminobutyric acid blocking epileptogen, crosses the normal BBB of rats poorly and produces no consistent abnormality behaviorally or on EEG of 36 mg/kg. When the BBB is opened in 0.25 ml of cortex by 6,000 rad of α particles, by a pin trauma lesion, or by a heat lesion, the rats are normal clinically and on EEG. When these lesioned rats are challenged with bicuculline methiodide, 36 mg/kg, an intense, highly localized epileptiform discharge results that begins ~20 min after injection and lasts 30-90 min. The plausibility and experimental utility of the BBB-epileptogen model of epilepsy are enhanced by these observations.

Original languageEnglish (US)
Pages (from-to)69-73
Number of pages5
JournalEpilepsia
Volume26
Issue number1
StatePublished - 1985

Fingerprint

Blood-Brain Barrier
Epilepsy
Electroencephalography
Aminobutyrates
Convulsants
Partial Epilepsy
Folic Acid
Penicillins
Hot Temperature
bicuculline methiodide
Injections
Wounds and Injuries

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Remler, M. P., & Marcussen, W. H. (1985). Bicuculline methiodide in the blood-brain barrier - epileptogen model of epilepsy. Epilepsia, 26(1), 69-73.

Bicuculline methiodide in the blood-brain barrier - epileptogen model of epilepsy. / Remler, M. P.; Marcussen, W. H.

In: Epilepsia, Vol. 26, No. 1, 1985, p. 69-73.

Research output: Contribution to journalArticle

Remler, MP & Marcussen, WH 1985, 'Bicuculline methiodide in the blood-brain barrier - epileptogen model of epilepsy', Epilepsia, vol. 26, no. 1, pp. 69-73.
Remler, M. P. ; Marcussen, W. H. / Bicuculline methiodide in the blood-brain barrier - epileptogen model of epilepsy. In: Epilepsia. 1985 ; Vol. 26, No. 1. pp. 69-73.
@article{0e47499364994352b5a0cf3e7a3f11dc,
title = "Bicuculline methiodide in the blood-brain barrier - epileptogen model of epilepsy",
abstract = "Focal epilepsy can be produced by a blood-brain barrier (BBB)-excluded systemic convulsant (penicillin, folic acid, etc.) in the presence of a focal BBB lesion. Bicuculline methiodide, a γ-aminobutyric acid blocking epileptogen, crosses the normal BBB of rats poorly and produces no consistent abnormality behaviorally or on EEG of 36 mg/kg. When the BBB is opened in 0.25 ml of cortex by 6,000 rad of α particles, by a pin trauma lesion, or by a heat lesion, the rats are normal clinically and on EEG. When these lesioned rats are challenged with bicuculline methiodide, 36 mg/kg, an intense, highly localized epileptiform discharge results that begins ~20 min after injection and lasts 30-90 min. The plausibility and experimental utility of the BBB-epileptogen model of epilepsy are enhanced by these observations.",
author = "Remler, {M. P.} and Marcussen, {W. H.}",
year = "1985",
language = "English (US)",
volume = "26",
pages = "69--73",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Bicuculline methiodide in the blood-brain barrier - epileptogen model of epilepsy

AU - Remler, M. P.

AU - Marcussen, W. H.

PY - 1985

Y1 - 1985

N2 - Focal epilepsy can be produced by a blood-brain barrier (BBB)-excluded systemic convulsant (penicillin, folic acid, etc.) in the presence of a focal BBB lesion. Bicuculline methiodide, a γ-aminobutyric acid blocking epileptogen, crosses the normal BBB of rats poorly and produces no consistent abnormality behaviorally or on EEG of 36 mg/kg. When the BBB is opened in 0.25 ml of cortex by 6,000 rad of α particles, by a pin trauma lesion, or by a heat lesion, the rats are normal clinically and on EEG. When these lesioned rats are challenged with bicuculline methiodide, 36 mg/kg, an intense, highly localized epileptiform discharge results that begins ~20 min after injection and lasts 30-90 min. The plausibility and experimental utility of the BBB-epileptogen model of epilepsy are enhanced by these observations.

AB - Focal epilepsy can be produced by a blood-brain barrier (BBB)-excluded systemic convulsant (penicillin, folic acid, etc.) in the presence of a focal BBB lesion. Bicuculline methiodide, a γ-aminobutyric acid blocking epileptogen, crosses the normal BBB of rats poorly and produces no consistent abnormality behaviorally or on EEG of 36 mg/kg. When the BBB is opened in 0.25 ml of cortex by 6,000 rad of α particles, by a pin trauma lesion, or by a heat lesion, the rats are normal clinically and on EEG. When these lesioned rats are challenged with bicuculline methiodide, 36 mg/kg, an intense, highly localized epileptiform discharge results that begins ~20 min after injection and lasts 30-90 min. The plausibility and experimental utility of the BBB-epileptogen model of epilepsy are enhanced by these observations.

UR - http://www.scopus.com/inward/record.url?scp=0021998989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021998989&partnerID=8YFLogxK

M3 - Article

VL - 26

SP - 69

EP - 73

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

IS - 1

ER -